[144] Beam Therapeutics Inc. SEC Filing
Rhea-AI Filing Summary
BEAM affiliate submitted a Form 144 notice proposing the sale of 20,000 shares of Common Stock. The filing lists the disposition method as Restricted Stock Vesting with an issuer-related transfer dated 03/31/2026. Recent reported sales by the same holder include $33,978.85 for 1,254 shares on 01/02/2026, $644,830.68 for 18,629 shares on 01/15/2026, and $46,614 for 1,371 shares on 01/22/2026. The cover records 101,856,245 shares (as of 04/02/2026).
Positive
- None.
Negative
- None.
Insights
Form 144 reports an affiliate's planned resale of vested restricted stock.
The filing lists a proposed sale of 20,000 shares tied to restricted stock vesting on 03/31/2026. Form 144 is a notice required under Rule 144 when affiliates intend to resell restricted or control securities; it does not itself execute a sale.
Cash‑flow treatment and timing are not specified here; subsequent brokered transactions or a Form 4/5 would show completed trades and final proceeds. Future filings will clarify whether these shares are sold on the open market or via another distribution method.